BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6976157)

  • 21. [Biological and immunological markers in acute leukaemia (author's transl)].
    López Borrasca A; González M; Hernández F; Ledesma M; Corrales A; San Miguel J
    Sangre (Barc); 1981; 26(5B):756-82. PubMed ID: 6275558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract]   [Full Text] [Related]  

  • 23. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
    Bogusławska-Jaworska J; Chybicka A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic markers in childhood acute lymphocytic leukemia.
    Crist WM; Grossi CE; Pullen DJ; Cooper MD
    Semin Oncol; 1985 Jun; 12(2):105-21. PubMed ID: 3892693
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 26. TdT in adult acute lymphoblastic leukemia: relationship with blast cell count.
    Baccarani M; Marini M; Bagnara GP; Gobbi M; Saviotti F; Brunelli MA; Tura S
    Haematologica; 1981 Oct; 66(5):579-87. PubMed ID: 6796467
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia.
    Greaves M; Verbi W; Vogler L; Cooper M; Ellis R; Ganeshaguru K; Hoffbrand V; Janossy G; Bollum FJ
    Leuk Res; 1979; 3(6):353-62. PubMed ID: 317656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
    Rupniewska ZM; Kniaź M
    Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
    [No Abstract]   [Full Text] [Related]  

  • 29. Surface markers in chronic lymphoid leukemias of B cell type.
    Caligaris-Cappio F; Janossy G
    Semin Hematol; 1985 Jan; 22(1):1-12. PubMed ID: 3881823
    [No Abstract]   [Full Text] [Related]  

  • 30. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Unmasking the heterogeneity of acute lymphoblastic leukemia.
    Gelfand EW; Chechik BE
    N Engl J Med; 1976 Jan; 294(5):275-6. PubMed ID: 1081642
    [No Abstract]   [Full Text] [Related]  

  • 32. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
    Seligmann M; Brouet JC; Preud'homme JL
    Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic phenotypes of acute lymphoblastic leukemias and their clinico-biological correlations].
    San Miguel JF; González M; Caballero MD; Moro MJ; Prieto M; Moraleda JM; Tamagnini G; López Borrasca A
    Sangre (Barc); 1984; 29(5):849-60. PubMed ID: 6596755
    [No Abstract]   [Full Text] [Related]  

  • 34. T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia.
    Belpomme D; Dantchev D; Du Rusquec E; Grandjon D; Huchet R; Pouillart P; Schwarzenberg L; Amiel JL; Mathé G
    Biomedicine; 1974 Mar; 20(2):109-18. PubMed ID: 4605201
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunological membrane markers in blasts and lymphocytes of patients with acute leukemia].
    Schwenk HU
    Fortschr Med; 1977 Sep; 95(33):2019-20. PubMed ID: 303208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J; Rodziewicz B
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of acute leukemia in childhood].
    Hirt A; Imbach P; Wagner HP
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):866-71. PubMed ID: 6984132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunobiological features of acute lymphoblastic leukaemia].
    Gavosto F
    Haematologica; 1983; 68(1):1-19. PubMed ID: 6404699
    [No Abstract]   [Full Text] [Related]  

  • 39. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
    von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical perspective on cell markers in acute lymphocytic leukemia.
    Bowman WP; Melvin SL; Aur RJ; Mauer AM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.